Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RGNX
#2557
REGENXBIO Inc.
9.040
0
+8.00%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+8.00%
Variazione Mensile
-5.88%
Variazione di 6 mesi
-32.69%
Variazione Annuale
-32.69%
Chiusura Precedente
8.370
0
Open
9.040
0
Bid
Ask
Low
9.040
0
High
9.040
0
Volume
78
Mercati
Mercato Azionario Statunitense
Salute
RGNX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
49.55 M
50.09 M
50.16 M
50.51 M
50.62 M
—
Valuation ratios
Enterprise value
463.11 M
329.64 M
228.54 M
335.16 M
429.71 M
1.32 B
Price to earnings ratio
-2.09
-1.68
-2.31
-2.4
-2.8
-9.2
Price to sales ratio
5.94
4.89
2.32
2.69
3.06
12.97
Price to cash flow ratio
2.73
2.21
2.39
4.71
4.76
14.07
Price to book ratio
0.37
1.47
0.31
0.4
0.54
2.72
Enterprise value to EBITDA ratio
-8.43
-5.56
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.11
0.01
0.12
0.12
0.36
Return on equity %
0.2
0.2
0.02
0.33
0.38
0.93
Return on invested capital %
—
38.89
—
—
—
—
Gross margin %
48.81
46.65
100
100
100
346.65
Operating margin %
256.55
242.14
13.62
296.26
176.27
728.3
EBITDA margin %
-53.27
-72.03
—
—
—
—
Net margin %
246.3
241.28
6.83
331.81
208.32
788.25
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.05
2.69
2.93
3.13
2.66
11.42
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.04
0.19
0.04
0.05
0.32
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.8
0.64
0.65
-0.35
1.08
2.03
EBIT per share
-0.23
-0.29
—
—
—
—
EBITDA per share
-0.25
-0.31
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.48
4.95
5.3
7.06
5.84
23.15
Net current asset value per share
6.17
5.62
6.09
7.26
6.42
25.39
Tangible book value per share
5.93
5.24
5.33
4.15
3.12
17.85
Working capital per share
4.15
3.53
4.01
4.94
4.01
16.5
Book value per share
5.93
5.24
5.33
4.15
3.12
17.85
Notizie
Stifel commenta le azioni uniQure dopo le dichiarazioni del commissario FDA
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)
Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection
Intel, Wells Fargo among market cap stock movers on Tuesday
Netflix and Oracle among market cap stock movers on Tuesday
Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback
Titoli dopo la chiusura: ON Semiconductor, Credo, Upwork, Regenxbio e altri
Il titolo REGENXBIO crolla dopo il rifiuto della FDA per la terapia genica